POMC and rheumatoid arthritis: The immune-suppressive effects of GCs were first reported by Hench et al. (1949), who demonstrated that adrenocorticotropic hormone (ACTH) and cortisone improved clinical features of rheumatoid arthritis patients (Hench et al., 1949).